{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:00:26Z","timestamp":1760551226163},"reference-count":0,"publisher":"Managed Care and Healthcare Communications, LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Manag Care"],"published-print":{"date-parts":[[2020,9,1]]},"DOI":"10.37765\/ajmc.2020.88489","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T15:18:38Z","timestamp":1600183118000},"page":"388-394","source":"Crossref","is-referenced-by-count":5,"title":["Comparing patient OOP spending for specialty drugs in Medicare Part D and employer-sponsored insurance"],"prefix":"10.37765","volume":"26","member":"24492","published-online":{"date-parts":[[2020,9,11]]},"container-title":["The American Journal of Managed Care"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T15:18:39Z","timestamp":1600183119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajmc.com\/view\/comparing-patient-oop-spending-for-specialty-drugs-in-medicare-part-d-and-employer-sponsored"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.37765\/ajmc.2020.88489","archive":["Portico","Portico"],"relation":{},"ISSN":["1936-2692","1088-0224"],"issn-type":[{"value":"1936-2692","type":"electronic"},{"value":"1088-0224","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}